{{Distinguish|Fenmetozole}}
{{Drugbox
| IUPAC_name = 2-Phenyl-3-methyl-morpholin-5-one
| image = Fenmetramide.png

<!--Clinical data-->
| tradename =  
| pregnancy_category =  
| legal_status =  
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability =  
| metabolism =  
| elimination_half-life =  
| excretion =

<!--Identifiers-->
| CAS_number = 5588-29-4
| ATC_prefix = None
| ATC_suffix =  
| PubChem = 21789
| ChemSpiderID = 20479
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = WCH9HW127L
| KEGG = D04153

<!--Chemical data-->
| C=11 | H=13 | N=1 | O=2 
| molecular_weight = 191.23 g/mol
| smiles = O=C1NC(C(OC1)c2ccccc2)C
}}

'''Fenmetramide''' is a [[drug]] which was patented as an [[antidepressant]] by [[McNeil Laboratories]] in the 1960s.<ref>US Patent 3308121 - 3-MORPHOLINONES, THIONES & 5,6 OXAZINES</ref> The drug was never marketed.<ref name="isbn0-412-46630-9">{{cite book | author = David J. Triggle | title = Dictionary of pharmacological agents | publisher = Chapman & Hall | location = London | year = 1997 | pages = | isbn = 0-412-46630-9 | oclc = | doi = | url = https://books.google.com/books?id=A0THacd46ZsC&lpg=PA1333&dq=fenmetramide&pg=PA1333#v=onepage&q=fenmetramide&f=false}}</ref> It is the 5-[[ketone]] [[chemical derivative|derivative]] of [[phenmetrazine]] and would similarly be expected to produce [[psychostimulant]] effects, though [[pharmacology|pharmacological]] data is lacking.

== See also ==
* [[Fenbutrazate]]
* [[Phendimetrazine]]
* [[Phenmetrazine]]

== References ==
{{Reflist}}

{{Antidepressants}}
{{Stimulants}}
{{Monoamine releasing agents}}

[[Category:Antidepressants]]
[[Category:Lactams]]
[[Category:Morpholines]]
[[Category:Stimulants]]
[[Category:Norepinephrine-dopamine releasing agents]]
[[Category:Abandoned drugs]]